QIPT vs. HTL, OGI, CPH, CRDL, FRX, MDNA, DR, EDT, VHI, and HLS
Should you be buying Quipt Home Medical stock or one of its competitors? The main competitors of Quipt Home Medical include Hamilton Thorne (HTL), Organigram (OGI), Cipher Pharmaceuticals (CPH), Cardiol Therapeutics (CRDL), Fennec Pharmaceuticals (FRX), Medicenna Therapeutics (MDNA), Medical Facilities (DR), Spectral Medical (EDT), Vitalhub (VHI), and HLS Therapeutics (HLS). These companies are all part of the "medical" sector.
Quipt Home Medical (TSE:QIPT) and Hamilton Thorne (TSE:HTL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, community ranking, profitability, earnings and analyst recommendations.
Hamilton Thorne has a net margin of -0.90% compared to Quipt Home Medical's net margin of -1.57%. Hamilton Thorne's return on equity of -1.00% beat Quipt Home Medical's return on equity.
In the previous week, Hamilton Thorne had 6 more articles in the media than Quipt Home Medical. MarketBeat recorded 8 mentions for Hamilton Thorne and 2 mentions for Quipt Home Medical. Quipt Home Medical's average media sentiment score of -0.09 beat Hamilton Thorne's score of -0.34 indicating that Quipt Home Medical is being referred to more favorably in the media.
Quipt Home Medical has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, Hamilton Thorne has a beta of 0.29, meaning that its share price is 71% less volatile than the S&P 500.
Quipt Home Medical received 11 more outperform votes than Hamilton Thorne when rated by MarketBeat users. However, 100.00% of users gave Hamilton Thorne an outperform vote while only 80.00% of users gave Quipt Home Medical an outperform vote.
Quipt Home Medical currently has a consensus target price of C$11.74, suggesting a potential upside of 154.11%. Given Quipt Home Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Quipt Home Medical is more favorable than Hamilton Thorne.
45.1% of Quipt Home Medical shares are owned by institutional investors. Comparatively, 19.5% of Hamilton Thorne shares are owned by institutional investors. 3.8% of Quipt Home Medical shares are owned by insiders. Comparatively, 27.8% of Hamilton Thorne shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Hamilton Thorne has lower revenue, but higher earnings than Quipt Home Medical. Hamilton Thorne is trading at a lower price-to-earnings ratio than Quipt Home Medical, indicating that it is currently the more affordable of the two stocks.
Summary
Quipt Home Medical beats Hamilton Thorne on 10 of the 19 factors compared between the two stocks.
Get Quipt Home Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for QIPT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding QIPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quipt Home Medical Competitors List
Related Companies and Tools
